Navigation Links
Transplant Societies Protest FDA Policy in American Journal of Transplantation
Date:3/19/2008

MOUNT LAUREL, N.J., March 19 /PRNewswire-USNewswire/ -- In an Open Letter to the Federal Drug Administrations (FDA), which appears in the April issue of the American Journal of Transplantation (AJT), the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) explain how FDA policy is thwarting the field of transplant medicine in the United States. Flavio Vincenti, MD, president of the AST and one of the letter's authors, described the letter as an appeal to the FDA to reconsider its policy.
Vincenti maintains that FDA policy has:

-- discouraged many transplant centers from participating in clinical

trials of new transplant drugs

-- driven American patients away from enrolling in clinical trials

-- caused drug companies to seek patients outside the U.S. for clinical

trials

-- weakened clinical trial results of innovative transplant drugs

In summary, FDA policy mandates the use of immunosuppressive drugs in organ transplantation clinical trials (in the control arms) that are no longer the preferred regimen of drugs of transplant physicians. The letter can be reviewed by going to http://www.a-s-t.org .

About AST

The American Society of Transplantation (AST) was founded in 1982 and is an organization of more than 2,700 transplant professionals dedicated to improving patient care through the promotion of research, education, advocacy and organ donation. AST provides a forum for the exchange of knowledge, scientific information and expertise in the field of transplantation.

If you are interested in speaking with the letter's primary author, Dr. Vincenti, or would like to receive a copy of the letter, please contact Beth Drost at 215.884.6499.

Contact: Beth Drost

215.884.6499


'/>"/>
SOURCE American Society of Transplantation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New technique improves outcome for living donor liver transplants
2. New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants
3. A new finding in liver transplantation and antifibrinolytics?
4. Transplant Network Appoints Cynthia Siljestrom CEO
5. NIH grant to Emory and pediatric partners aims to improve kidney transplants for children
6. Study of 137 Meniscus Transplant Procedures in Patients with Arthritis is Presented to the Meniscus Transplantation Study Group at the American Academy of Orthopaedic Surgeons Annual Meeting
7. Survival rates exceed national averages for UCSF heart, liver and lung transplant programs
8. Double Lung Transplant Better for Younger COPD Patients
9. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
10. Race, insurance status affect access to transplantation and kidney disease treatment
11. A device that measures optimum state of an organ prior to transplanting has been patented
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... They are musicians and librarians, fashion designers and fitness instructors, actors, athletes and ... around the nation. What do they have in common? All have been affected by ... new photographic exhibit debuting Friday, December 9 at Logan International Airport in Boston. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... When it came time to blow out his candles on ... later, the Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his ... the hospital’s 30th heart transplant recipient. , “He was playing at home, when we ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... connectors, is now promoting to the US market its advanced highly customizable contact ... and ODU TURNTAC®. These advanced technologies are ideal for a wide range ...
(Date:12/7/2016)... MI (PRWEB) , ... December 07, 2016 , ... ... and financial consultation services from offices located in South Lyon, Dewitt, Williamston, East ... benefit a basketball coach who needs treatment for a brain tumor. , Jason ...
(Date:12/7/2016)... Folsom, CA (PRWEB) , ... December 07, 2016 ... ... that provides insurance and financial consultation services to residents in the Sacramento/Folsom region, ... Choice Another Chance treatment facility. , The Another Choice Another Chance treatment center ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ... present a company overview at the BMO Capital Markets Prescriptions for ... York, NY . A live webcast of the ... the Ionis website.  The replay will be available within 48 hours ... ...
(Date:12/7/2016)... 7, 2016 Today, Stock-Callers.com presents four ... JAZZ ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ... AveXis Inc. (NASDAQ: AVXS ). From its peak ... 37% to reach a level equal to what it saw ... approximately 14% for the year, it has still out-performed other ...
(Date:12/7/2016)... According to the latest market ... Study on Multiplex Detection Immunoassay: North America to Dominate ... detection immunoassay market is expected to witness a CAGR of ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
Breaking Medicine Technology: